A Prospective Clinical Study of CD3-CD20 Bisspecific Antibody Based Therapy Combined With CD19-CAR T Cells in the Treatment of Relapsed Refractory B-cell Non-Hodgkin Lymphoma

Name: A Prospective Clinical Study of CD3-CD20 Bisspecific Antibody Based Therapy Combined With CD19-CAR T Cells in the Treatment of Relapsed Refractory B-cell Non-Hodgkin Lymphoma
License: Public Domain

Institute of Hematology & Blood Diseases Hospital, China

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

b-cell non-hodgkin lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 628547
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.